Ubs Group Ag V Tv Therapeutics Inc. Transaction History

Ubs Group Ag

  • $397 Billion
  • Q1 2024

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023
SELL
$0.72 - $1.01 $4,921 - $6,904
-6,836 Reduced 87.7%
959 $0
Q4 2022

Feb 08, 2023
SELL
$0.66 - $1.02 $3,936 - $6,084
-5,965 Reduced 43.35%
7,795 $5,000
Q3 2022

Nov 10, 2022
BUY
$0.65 - $1.37 $8,944 - $18,851
13,760 New
13,760 $13,000
Q1 2022

May 16, 2022
SELL
$0.51 - $1.0 $8,614 - $16,892
-16,892 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$0.95 - $1.69 $16,047 - $28,547
16,892 New
16,892 $17,000
Q3 2021

Nov 15, 2021
SELL
$1.53 - $2.22 $16,233 - $23,554
-10,610 Closed
0 $0
Q2 2021

Aug 13, 2021
BUY
$2.27 - $3.44 $15,193 - $23,023
6,693 Added 170.87%
10,610 $24,000
Q1 2021

May 12, 2021
SELL
$1.97 - $2.89 $10,866 - $15,941
-5,516 Reduced 58.48%
3,917 $11,000
Q4 2020

Feb 11, 2021
BUY
$1.49 - $3.1 $1,308 - $2,721
878 Added 10.26%
9,433 $18,000
Q3 2020

Nov 12, 2020
BUY
$1.7 - $2.98 $7,197 - $12,617
4,234 Added 97.99%
8,555 $15,000
Q2 2020

Jul 31, 2020
BUY
$1.74 - $3.19 $5,778 - $10,593
3,321 Added 332.1%
4,321 $9,000
Q3 2019

Nov 14, 2019
SELL
$1.26 - $1.77 $11,527 - $16,193
-9,149 Reduced 90.15%
1,000 $2,000
Q2 2019

Aug 14, 2019
BUY
$1.29 - $1.83 $9,653 - $13,693
7,483 Added 280.68%
10,149 $14,000
Q1 2019

May 14, 2019
SELL
$1.67 - $3.12 $6,401 - $11,958
-3,833 Reduced 58.98%
2,666 $5,000
Q4 2018

Feb 14, 2019
SELL
$0.78 - $3.74 $2,721 - $13,048
-3,489 Reduced 34.93%
6,499 $18,000
Q3 2018

Nov 14, 2018
BUY
$0.7 - $1.58 $6,237 - $14,079
8,911 Added 827.39%
9,988 $8,000
Q2 2018

Aug 14, 2018
BUY
$0.71 - $4.04 $54 - $311
77 Added 7.7%
1,077 $2,000
Q1 2018

May 15, 2018
BUY
$3.91 - $7.83 $1,118 - $2,239
286 Added 40.06%
1,000 $4,000
Q4 2017

Feb 14, 2018
BUY
$3.9 - $7.77 $1,864 - $3,714
478 Added 202.54%
714 $4,000
Q3 2017

Nov 14, 2017
SELL
$3.83 - $6.07 $245 - $388
-64 Reduced 21.33%
236 $1,000
Q2 2017

Aug 14, 2017
BUY
N/A
58 Added 23.97%
300 $1,000
Q1 2017

Nov 14, 2017
BUY
N/A
242
242 $2,000

Others Institutions Holding VTVT

# of Institutions
1
Shares Held
243K
Call Options Held
0
Put Options Held
0
View Full List

About vTv Therapeutics Inc.

VTVT Quotes by TradingView
  • Ticker VTVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 81,483,600
  • Market Cap $1.43B
  • Description
  • vTv Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on the development of orally administered treatments for diabetes. The company is developing TTP399, an orally administered, small molecule, and liver-selective glucokinase activator for the treatment of type 1 diabetes; and HPP737, an orally administered non-CNS penetran...
More about VTVT
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email